About Illinois CancerCare-Kewanee Clinic
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
153
Alliance for Clinical Trials in Oncology
74
SWOG Cancer Research Network
57
ECOG-ACRIN Cancer Research Group
26
NRG Oncology
8
Wake Forest University Health Sciences
6
GOG Foundation
5
Gynecologic Oncology Group
5
NSABP Foundation Inc
5
Children's Oncology Group
2
Eastern Cooperative Oncology Group
2
Clinical Trials at Illinois CancerCare-Kewanee Clinic
During the past decade, Illinois CancerCare-Kewanee Clinic conducted 178 clinical trials. In the 10-year time frame, 178 clinical trials started and 149 clinical trials were completed, i.e. on
average, 83.7% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 69 clinical trials were completed. i.e. 113.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
1984-06-01
Active, not recruiting
9,000
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
2003-11-01
2027-01-01
Active, not recruiting
3,294
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
2004-09-01
2013-05-01
Completed
52
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
2005-03-01
2018-08-01
Completed
4,216
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
2006-03-01
2015-08-01
Completed
97
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
2005-07-26
2022-05-20
Completed
70
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Illinois CancerCare-Kewanee Clinic" #1 sponsor was "National Cancer Institute (NCI)" with 153 trials, followed by "Alliance for Clinical Trials in Oncology" with 74 trials
sponsored, "SWOG Cancer Research Network" with 57 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 26 trials sponsored and "NRG Oncology"
with 26 trials sponsored. Other sponsors include 22 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois CancerCare-Kewanee Clinic"
#1 collaborator was "National Cancer Institute (NCI)" with 190 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 41 different institutions and companies that were
collaborators in the rest 37 trials.
Clinical Trials Conditions at Illinois CancerCare-Kewanee Clinic
According to Clinical.Site data, the most researched conditions in "Illinois CancerCare-Kewanee Clinic" are
"Breast Cancer" (17 trials), "Stage IV Lung Cancer AJCC v8" (11 trials), "Invasive Breast Carcinoma" (10 trials), "Recurrent Breast Carcinoma" (10 trials) and "Recurrent Ovarian Carcinoma" (10 trials). Many other conditions were trialed in "Illinois CancerCare-Kewanee Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Illinois CancerCare-Kewanee Clinic
Most popular intervention types in "Illinois CancerCare-Kewanee Clinic" are "Drug" (279 trials), "Other" (209 trials), "Biological" (136 trials), "Procedure" (83 trials) and "Radiation" (51 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (92 trials), "Quality-of-Life Assessment" (81 trials), "Questionnaire Administration" (55 trials), "Computed Tomography" (42 trials) and "Biospecimen Collection" (40 trials). Other intervention names were less common.
Clinical Trials Genders at Illinois CancerCare-Kewanee Clinic
The vast majority of trials in "Illinois CancerCare-Kewanee Clinic" are
285 trials for "All" genders, 51 trials for "Female" genders and 9 trials for "Male" genders.
Clinical Trials Status at Illinois CancerCare-Kewanee Clinic
Currently, there are NaN active trials in "Illinois CancerCare-Kewanee Clinic".
undefined are not yet recruiting,
89 are recruiting,
138 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 90 completed trials in Illinois CancerCare-Kewanee Clinic,
9 suspended trials,
and 16 terminated clinical trials to date.
Out of the total trials that were conducted in Illinois CancerCare-Kewanee Clinic, 20 "Phase 1"
clinical trials were conducted, 175 "Phase 2" clinical
trials and 164 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 8 trials that are defined as “Not Applicable".